Cortical thickness analysis to detect progressive mild cognitive impairment: A reference to alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 28, Issue 5, 2009, Pages 404-412

  Julkunen, Valtteri ^a   Niskanen, Eini ^b   Muehlboeck, Sebastian ^c   Pihlajamäki, Maija ^a,b   Könönen, Mervi ^a   Hallikainen, Merja ^b   Kivipelto, Miia ^a,d   Tervo, Susanna ^b   Vanninen, Ritva ^a   Evans, Alan ^c   Soininen, Hilkka ^a,b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c MCGILL UNIVERSITY   (Canada)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Alzheimer's disease; Cortical thickness; Magnetic resonance imaging; Mild cognitive impairment

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORT; BRAIN CORTEX; BRAIN REGION; BRAIN SIZE; CINGULATE GYRUS; CLINICAL ASSESSMENT; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DISEASE COURSE; FEMALE; FOLLOW UP; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CEREBRAL CORTEX; COGNITION DISORDERS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 70449513127     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000256274     Document Type: Article

References (56)

1. Petersen RC: Mild cognitive impairment as a diagnostic entity. J Intern Med 2004; 256: 183-194.
2. Petersen RC: Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56: 1133-1142.
3. Schneider JA, Arvanitakis Z, Leurgans SE, Bennett DA: The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol 2009; 66: 200-208.
4. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P: Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol 2007; 6: 734-746.
5. Braak H, Braak E: Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239-259.
6. Kordower JH, Chu Y, Stebbins GT, DeKosky ST, Cochran EJ, Bennett D, Mufson EJ: Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann Neurol 2001; 49: 202-213.
7. De Santi S, de Leon MJ, Rusinek H, Convit A, Tarshish CY, Roche A, Tsui WH, Kandil E, Boppana M, Daisley K, Wang GJ, Schlyer D, Fowler J: Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol Aging 2001; 22: 529-539.
8. Du AT, Schuff N, Kramer JH, Rosen HJ, Gorno-Tempini ML, Rankin K, Miller BL, Weiner MW: Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia. Brain 2007; 130: 1159-1166.
9. Pennanen C, Kivipelto M, Tuomainen S, Hartikainen P, Hänninen T, Laakso MP, Hallikainen M, Vanhanen M, Nissinen A, Helkala EL, Vainio P, Vanninen R, Partanen K, Soininen H: Hippocampus and entorhinal cortex in mild cognitive impairment and early AD. Neurobiol Aging 2004; 25: 303-310.
10. Uotani C, Sugimori K, Kobayashi K: Association of minimal thickness of the medial temporal lobe with hippocampal volume, maximal and minimal hippocampal length: Volumetric approach with horizontal magnetic resonance imaging scans for evaluation of a diagnostic marker for neuroimaging of Alzheimer's disease. Psychiatry Clin Neurosci 2006; 60: 319-326.
11. Tapiola T, Pennanen C, Tapiola M, Tervo S, Kivipelto M, Hänninen T, Pihlajamäki M, Laakso MP, Hallikainen M, Hämäläinen A, Vanhanen M, Helkala EL, Vanninen R, Nissinen A, Rossi R, Frisoni GB, Soininen H: MRI of hippocampus and entorhinal cortex in mild cognitive impairment: A follow-up study. Neurobiol Aging 2008; 29: 31-38.
12. Jack CR Jr, Shiung MM, Gunter JL, O'Brien PC, Weigand SD, Knopman DS, Boeve BF, Ivnik RJ, Smith GE, Cha RH, Tangalos EG, Petersen RC: Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology 2004; 62: 591-600.
13. Jack CR Jr, Petersen RC, Xu YC, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Waring SC, Tangalos EG, Kokmen E: Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999; 52: 1397-1403.
14. Ashburner J, Friston KJ: Voxel-based morphometry - the methods. Neuroimage 2000; 11: 805-821.
15. Bell-McGinty S, Lopez OL, Meltzer CC, Scanlon JM, Whyte EM, Dekosky ST, Becker JT: Differential cortical atrophy in subgroups of mild cognitive impairment. Arch Neurol 2005; 62: 1393-1397.
16. Chetelat G, Landeau B, Eustache F, Mezenge F, Viader F, de la Sayette V, Desgranges B, Baron JC: Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: A longitudinal MRI study. Neuroimage 2005; 27: 934-946.
17. Fan Y, Batmanghelich N, Clark CM, Davatzikos C, the Alzheimer's Disease Neuroimaging Initiative: Spatial patterns of brain atrophy in MCI patients, identified via highdimensional pattern classification, predict subsequent cognitive decline. Neuroimage 2008; 39: 1731-1743.
18. Hämäläinen A, Tervo S, Grau-Olivares M, Niskanen E, Pennanen C, Huuskonen J, Kivipelto M, Hänninen T, Tapiola M, Vanhanen M, Hallikainen M, Helkala EL, Nissinen A, Vanninen R, Soininen H: Voxel-based morphometry to detect brain atrophy in progressive mild cognitive impairment. Neuroimage 2007; 37: 1122-1131.
19. Jack CR Jr, Weigand SD, Shiung MM, Przybelski SA, O'Brien PC, Gunter JL, Knopman DS, Boeve BF, Smith GE, Petersen RC: Atrophy rates accelerate in amnestic mild cognitive impairment. Neurology 2008; 70: 1740-1752.
20. Whitwell JL, Shiung MM, Przybelski SA, Weigand SD, Knopman DS, Boeve BF, Petersen RC, Jack CR Jr: MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment. Neurology 2008; 70: 512-520.
21. Lerch JP, Pruessner JC, Zijdenbos A, Hampel H, Teipel SJ, Evans AC: Focal decline of cortical thickness in Alzheimer's disease identified by computational neuroanatomy. Cereb Cortex 2005; 15: 995-1001.
22. Lerch JP, Evans AC: Cortical thickness analysis examined through power analysis and a population simulation. Neuroimage 2005; 24: 163-173.
23. Kim JS, Singh V, Lee JK, Lerch J, Ad-Dab'bagh Y, MacDonald D, Lee JM, Kim SI, Evans AC: Automated 3-D extraction and evaluation of the inner and outer cortical surfaces using a Laplacian map and partial volume effect classification. Neuroimage 2005; 27: 210-221.
24. Tohka J, Zijdenbos A, Evans A: Fast and robust parameter estimation for statistical partial volume models in brain MRI. Neuroimage 2004; 23: 84-97.
25. Rakic P: Specification of cerebral cortical areas. Science 1988; 241: 170-176.
26. Singh V, Chertkow H, Lerch JP, Evans AC, Dorr AE, Kabani NJ: Spatial patterns of cortical thinning in mild cognitive impairment and Alzheimer's disease. Brain 2006; 129: 2885-2893. (Pubitemid 44684510)
27. Im K, Lee JM, Seo SW, Yoon U, Kim ST, Kim YH, Kim SI, Na DL: Variations in cortical thickness with dementia severity in Alzheimer's disease. Neurosci Lett 2008; 436: 227-231.
28. Lerch JP, Pruessner J, Zijdenbos AP, Collins DL, Teipel SJ, Hampel H, Evans AC: Automated cortical thickness measurements from MRI can accurately separate Alzheimer's patients from normal elderly controls. Neurobiol Aging 2008; 29: 23-30.
29. Apostolova LG, Steiner CA, Akopyan GG, Dutton RA, Hayashi KM, Toga AW, Cummings JL, Thompson PM: Three-dimensional gray matter atrophy mapping in mild cognitive impairment and mild Alzheimer disease. Arch Neurol 2007; 64: 1489-1495.
30. Richards BA, Chertkow H, Singh V, Robillard A, Massoud F, Evans AC, Kabani NJ: Patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia. Neurobiol Aging 2009; 30: 1626-1636.
31. Bakkour A, Morris JC, Dickerson BC: The cortical signature of prodromal AD: Regional thinning predicts mild AD dementia. Neurology 2009; 72: 1048-1055.
32. Misra C, Fan Y, Davatzikos C: Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: Results from ADNI. Neuroimage 2009; 44: 1415-1422.
33. Seo SW, Im K, Lee JM, Kim YH, Kim ST, Kim SY, Yang DW, Kim SI, Cho YS, Na DL: Cortical thickness in single-versus multiple-domain amnestic mild cognitive impairment. Neuroimage 2007; 36: 289-297.
34. McEvoy LK, Fennema-Notestine C, Roddey JC, Hagler DJ Jr, Holland D, Karow DS, Pung CJ, Brewer JB, Dale AM: Alzheimer disease: Quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment. Radiology 2009; 251: 195-205.
35. Walhovd KB, Fjell AM, Amlien I, Grambaite R, Stenset V, Bjornerud A, Reinvang I, Gjerstad L, Cappelen T, Due-Tonnessen P, Fladby T: Multimodal imaging in mild cognitive impairment: Metabolism, morphometry and diffusion of the temporal-parietal memory network. Neuroimage 2009; 45: 215-223.
36. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL: A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 140: 566-572.
37. Kluger A, Ferris SH, Golomb J, Mittelman MS, Reisberg B: Neuropsychological prediction of decline to dementia in nondemented elderly. J Geriatr Psychiatry Neurol 1999; 12: 168-179.
38. Feldman HH, Ferris SH, Winblad B, Sfikas N, Mancione L, Yunsheng H, Tekin S, Burns A, Cummings J, del Ser T, Inzitari D, Orgogozo J, Sauer H, Scheltens P, Scarpini E, Herrmann N, Farlow M, Potkin S, Charles HC, Fox NC, Lane R: Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: The InDDEx study. Lancet Neurol 2007; 6: 501-512.
39. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994.
40. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
41. Hamilton M: Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6: 278-296.
42. Mazziotta J, Toga A, Evans A, Fox P, Lancaster J, Zilles K, Woods R, Paus T, Simpson G, Pike B, Holmes C, Collins L, Thompson P, MacDonald D, Iacoboni M, Schormann T, Amunts K, Palomero-Gallagher N, Geyer S, Parsons L, Narr K, Kabani N, Le Goualher G, Boomsma D, Cannon T, Kawashima R, Mazoyer B: A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM). Philos Trans R Soc Lond B Biol Sci 2001; 356: 1293-1322.
43. Sled JG, Zijdenbos AP, Evans AC: A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging 1999; 17: 87-97.
44. Smith SM: Fast robust automated brain extraction. Hum Brain Mapp 2002; 17: 143-155.
45. Zijdenbos A: Automatic quantification of MS lesions in 3D MRI brain data sets: Validation of INSECT; in Proc MICCAI, Cambridge, 1998, vol 1496, pp 439-448.
46. MacDonald D, Kabani N, Avis D, Evans AC: Automated 3-D extraction of inner and outer surfaces of cerebral cortex from MRI. Neuroimage 2000; 12: 340-356.
47. Chung MK, Taylor J: Diffusion smoothing on brain surface via finite element method. IEEE International Symposium on Biomedical Imaging: Macro to Nano. Proc IEEE Int Symp Biomed Imaging 2004; 1: 425-435.
48. Genovese CR: Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 2002; 15: 870-878.
49. Karas GB: Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease. Neuroimage 2004; 23: 708-716.
50. Dickerson BC, Bakkour A, Salat DH, Feczko E, Pacheco J, Greve DN, Grodstein F, Wright CI, Blacker D, Rosas HD, Sperling RA, Atri A, Growdon JH, Hyman BT, Morris JC, Fischl B, Buckner RL: The cortical signature of Alzheimer's disease: Regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex 2009; 19: 497-510.
51. Whitwell JL, Petersen RC, Negash S, Weigand SD, Kantarci K, Ivnik RJ, Knopman DS, Boeve BF, Smith GE, Jack CR Jr: Patterns of atrophy differ among specific subtypes of mild cognitive impairment. Arch Neurol 2007; 64: 1130-1138.
52. Whitwell JL, Przybelski SA, Weigand SD, Knopman DS, Boeve BF, Petersen RC, Jack CR Jr: 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. Brain 2007; 130: 1777-1786.
53. Davatzikos C, Fan Y, Wu X, Shen D, Resnick SM: Detection of prodromal Alzheimer's disease via pattern classification of magnetic resonance imaging. Neurobiol Aging 2008; 29: 514-523.
54. Vemuri P, Wiste HJ, Weigand SD, Shaw LM, Trojanowski JQ, Weiner MW, Knopman DS, Petersen RC, Jack CR Jr; the Alzheimer's Disease Neuroimaging Initiative: MRI and CSF biomarkers in normal, MCI, and AD subjects: Diagnostic discrimination and cognitive correlations. Neurology 2009; 73: 287-293.
55. Jack CR Jr, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, Knopman DS, Shiung MM, Gunter JL, Boeve BF, Kemp BJ, Weiner M, Petersen RC; the Alzheimer's Disease Neuroimaging Initiative: Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: Implications for sequence of pathological events in Alzheimer's disease. Brain 2009; 132: 1355-1365.
56. Jack CR Jr, Lowe VJ, Senjem ML, Weigand SD, Kemp BJ, Shiung MM, Knopman DS, Boeve BF, Klunk WE, Mathis CA, Petersen RC: 11 C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain 2008; 131: 665-680.